BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7633654)

  • 1. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma.
    Kashiwaba M; Tamura G; Ishida M
    Virchows Arch; 1995; 426(5):441-6. PubMed ID: 7633654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
    Zhang J; Ding F; Wang X
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.
    Iino H; Fukayama M; Maeda Y; Koike M; Mori T; Takahashi T; Kikuchi-Yanoshita R; Miyaki M; Mizuno S; Watanabe S
    Cancer; 1994 Mar; 73(5):1324-31. PubMed ID: 7906606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at the DCC gene locus is not crucial for the acquisition of metastatic potential in oesophageal squamous cell carcinoma.
    Maesawa C; Tamura G; Ogasawara S; Suzuki Y; Sakata K; Sugimura J; Nishizuka S; Sato N; Ishida K; Saito K; Satodate R
    Eur J Cancer; 1996 May; 32A(5):896-8. PubMed ID: 9081374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCC genetic alterations and expression in endometrial carcinoma.
    Ronnett BM; Burks RT; Cho KR; Hedrick L
    Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codon 201Arg/Gly polymorphism of DCC (deleted in colorectal carcinoma) gene in flat- and polypoid-type colorectal tumors.
    Minami R; Aoyama N; Honsako Y; Kasuga M; Fujimori T; Maeda S
    Dig Dis Sci; 1997 Dec; 42(12):2446-52. PubMed ID: 9440618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
    Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
    Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Fukunari H; Tanaka K; Miyaki M
    Cancer Res; 1992 Jul; 52(13):3801-3. PubMed ID: 1319833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
    Brewster SF; Browne S; Brown KW
    J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors.
    Schenk M; Leib-Mösch C; Schenck IU; Jaenicke M; Indraccolo S; Saeger HD; Dallenbach-Hellweg G; Hehlmann R
    J Mol Med (Berl); 1996 Mar; 74(3):155-9. PubMed ID: 8846166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.
    Enomoto T; Fujita M; Cheng C; Nakashima R; Ozaki M; Inoue M; Nomura T
    Br J Cancer; 1995 Mar; 71(3):462-7. PubMed ID: 7880725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion analysis of chromosome 8p in sporadic colorectal adenomas.
    Cunningham C; Dunlop MG; Bird CC; Wyllie AH
    Br J Cancer; 1994 Jul; 70(1):18-20. PubMed ID: 8018534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].
    Gao S; Xu W; Wan Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):250-2. PubMed ID: 9387312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.
    Saegusa M; Takano Y; Kamata Y; Okayasu J
    J Cancer Res Clin Oncol; 1996; 122(7):427-32. PubMed ID: 8690754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of loss of heterozygosity and mRNA expression at DCC locus in gastric cancers].
    Wang D; Fang D; Luo Y
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):331-4. PubMed ID: 9387268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of allele loss on chromosome 16q in DNA isolated from fine needle aspiration specimens of breast tumors. A simulation study using surgically resected specimens.
    Tsuda H; Sakamaki C; Shimamura K; Hirohashi S
    Acta Cytol; 1996; 40(4):625-30. PubMed ID: 8693876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the deleted in colorectal carcinoma gene in human primary leukemia.
    Miyake K; Inokuchi K; Dan K; Nomura T
    Blood; 1993 Aug; 82(3):927-30. PubMed ID: 8338956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCC gene alteration in human endometrial carcinomas.
    Gima T; Kato H; Honda T; Imamura T; Sasazuki T; Wake N
    Int J Cancer; 1994 May; 57(4):480-5. PubMed ID: 7514150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.